B Cell Targeted Induction to Improve Outcomes in Pediatric Lung Transplantation (CTOTC-08)
Phase of Trial: Phase II
Latest Information Update: 21 Aug 2019
Price : $35 *
At a glance
- Drugs Rituximab (Primary) ; Antithymocyte globulin; MMF; Steroids; Tacrolimus
- Indications Lung transplant rejection
- Focus Therapeutic Use
- 15 Aug 2019 Status changed from active, no longer recruiting to completed.
- 30 Oct 2018 Planned End Date changed from 1 Aug 2019 to 1 Jan 2020.
- 30 Oct 2018 Planned primary completion date changed from 1 Aug 2019 to 1 Jan 2020.